Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.

Cryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospectiv...

Full description

Bibliographic Details
Main Authors: Anand Moodley, William Rae, Ahmed Bhigjee, Cathy Connolly, Natasha Devparsad, Andrew Michowicz, Thomas Harrison, Angela Loyse
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3528708?pdf=render
id doaj-23239067b4cc4951b48681ca3c4e6bff
record_format Article
spelling doaj-23239067b4cc4951b48681ca3c4e6bff2020-11-24T20:45:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5289510.1371/journal.pone.0052895Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.Anand MoodleyWilliam RaeAhmed BhigjeeCathy ConnollyNatasha DevparsadAndrew MichowiczThomas HarrisonAngela LoyseCryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients underwent Humphrey's visual field (HVF) testing. Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the main abnormality with mean latency values of 118.9 (±16.5) ms and 119.8 (±15.7) ms for the right and left eyes respectively, mildly prolonged when compared to our laboratory references of 104 (±10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of normal eyes and constituted mostly latency abnormality. VEP amplitude was also significantly reduced in this cohort but minimally so in the visually unimpaired. HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant field defect was peripheral constriction with an enlarged blind spot suggesting the greater impact by raised intracranial pressure over that of optic neuritis. Whether this was due to papilloedema or a compartment syndrome is open to further investigation. Subclinical HVF abnormalities were minimal and therefore a poor screening test for early optic nerve dysfunction. However, early optic nerve dysfunction can be detected by testing of VEP P100 latency, which may precede the onset of visual loss in CM.http://europepmc.org/articles/PMC3528708?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Anand Moodley
William Rae
Ahmed Bhigjee
Cathy Connolly
Natasha Devparsad
Andrew Michowicz
Thomas Harrison
Angela Loyse
spellingShingle Anand Moodley
William Rae
Ahmed Bhigjee
Cathy Connolly
Natasha Devparsad
Andrew Michowicz
Thomas Harrison
Angela Loyse
Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
PLoS ONE
author_facet Anand Moodley
William Rae
Ahmed Bhigjee
Cathy Connolly
Natasha Devparsad
Andrew Michowicz
Thomas Harrison
Angela Loyse
author_sort Anand Moodley
title Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
title_short Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
title_full Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
title_fullStr Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
title_full_unstemmed Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
title_sort early clinical and subclinical visual evoked potential and humphrey's visual field defects in cryptococcal meningitis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Cryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients underwent Humphrey's visual field (HVF) testing. Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the main abnormality with mean latency values of 118.9 (±16.5) ms and 119.8 (±15.7) ms for the right and left eyes respectively, mildly prolonged when compared to our laboratory references of 104 (±10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of normal eyes and constituted mostly latency abnormality. VEP amplitude was also significantly reduced in this cohort but minimally so in the visually unimpaired. HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant field defect was peripheral constriction with an enlarged blind spot suggesting the greater impact by raised intracranial pressure over that of optic neuritis. Whether this was due to papilloedema or a compartment syndrome is open to further investigation. Subclinical HVF abnormalities were minimal and therefore a poor screening test for early optic nerve dysfunction. However, early optic nerve dysfunction can be detected by testing of VEP P100 latency, which may precede the onset of visual loss in CM.
url http://europepmc.org/articles/PMC3528708?pdf=render
work_keys_str_mv AT anandmoodley earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT williamrae earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT ahmedbhigjee earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT cathyconnolly earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT natashadevparsad earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT andrewmichowicz earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT thomasharrison earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
AT angelaloyse earlyclinicalandsubclinicalvisualevokedpotentialandhumphreysvisualfielddefectsincryptococcalmeningitis
_version_ 1716813808382509056